Strategic Acquisitions:
Boston Scientific's recent acquisitions, including Axonics, Relievant Medsystems, and partial offer for Acotec, signify its proactive expansion strategy, targeting new growth opportunities in medical segments and lucrative markets like China.
Innovative Product Introductions:
Introduction of innovative products strengthens Boston...
With a recent surge to record highs, fueled by positive developments and robust financial performance, here's a compelling case for potential buyers to consider adding NYSE:BSX stock to their portfolios.
1. Technical Analysis: Riding the Rising Trend Channel
Boston Scientific is currently riding a rising trend channel in the medium to long term, reflecting...
I'm not sure that this is valid now, because I'm not sure if the resistance line is built correctly and is it there at all?... In any case, there is a bounce and it is dynamic.
Pay attention to the moving average. After the price broke through and tested it in September, we saw 86% gain at the peak. If the past repeats itself now, we may well expect a similar scenario. Also, look at the volumes - there is an accumulation.
Can this be called testing after the breakdown of descending channel? Probably. Long candle wicks can indicate about low asset liquidity, therefore slightly spoiling the overall picture. Based on the fact that we probably tested descending channel and showed the 6th largest green bar of the histogram, it can be argued that this is a good entry point, considering...
Promising permissionless liquidity parachain on Kusama. Liquidity mining will be launched soon, which will definitely bring in new money and probably create a supply and demand shock for BSX . The price will at least bounce to the strongest and most important zone - $0.00013
Areas in white rectangles show very similar price pattern and both lead to a should of the head and shoulders pattern present on the diagonal uptrend line
A larger double top can be observed between these two peaks
All these assumptions support a downward move on this Weekly timeframe
NYSE:BSX
From a technical standpoint #BSX is reporting a divergence between RSI and Price, in addition the MACD is sloping up leading us to think that a move to the upside is imminent.
The MACD, still below 0, correctly describe the negative momentum: we expect for the near future to retest the upper end of the downward channel at $ 36.50.
Buy price: $...
Quantamental Tools for Proprietary and Retail Investors.
Statistical Arbitrage Opportunities Delivered to Your Inbox.
QuantChart. io
Long 100 $BSX
Short 81 $XRAY
Mean Reversion Time: 8 Trading Days
Quantamental Tools for Proprietary and Retail Investors.
Statistical Arbitrage Opportunities Delivered to Your Inbox.
QuantChart. io
Long 100 $BSX
Short 81 $XRAY
Mean Reversion Time: 8 Trading Days
Watchlist
One of the nicer looking charts
Price trading above 21/65/200 EMA
Watch for break of trendline
Slight increase in volume over the past few days
Watch 18c level
Not a stock I would generally get involved with but this one has my interest. Inverted H&S formations that breakout & drive the price higher combined with bullish indicators make this interesting. But then these days, throw a stone & it will hit a bullish stockFace with tongue
Just when things were getting interesting, we get a doji...sitting on my hands again whilst the price action decides its future. Retest of the $0.14c - $0.15c zone is a possibility
We keep seeing Clinical Stage Companies that are publicly traded, with new FDA Approvals, and the stocks are blasting off. Many of those are trading over $100 with no revenue, profits or earnings.
Here Merck is, sitting under $100, beating earnings, with record revenue and profit, and paying an almost 3.00% dividend....It is simply outrageous. Wall Street...
BSX hit its speculative entry as it broken below $29 label, and now it seems breaking down its Upward channel formation. We would consider a secondary entry at the confirmation break of upward channel around $27.60
* Trade Criteria *
Date First Found- October 25, 2017
Pattern/Why- Upward channel breakdown short
Entry Target Criteria- Break of $29...
